Full Text View
Tabular View
No Study Results Posted
Related Studies
Abiraterone Acetate in Patients With Prostate Cancer Who Have Failed Hormone Therapy
This study has been completed.
Study NCT00473512   Information provided by Cougar Biotechnology, Inc.

First Received on May 11, 2007.   Last Updated on December 24, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Neoplasms
Additional conditions recognized in this trial
Neoplasms
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Phase 1: abiraterone acetate
Phase 2: abiraterone acetate
Additional drug interventions recognized in this trial
Hormones
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Cougar Biotechnology, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services